Last reviewed · How we verify

Tiropramide HCl 100mg

Daewoong Pharmaceutical Co. LTD. · FDA-approved active Small molecule Quality 0/100

Tiropramide HCl 100mg is a Small molecule drug developed by Daewoong Pharmaceutical Co. LTD.. It is currently FDA-approved.

Tiropramide HCl 100mg, marketed by Daewoong Pharmaceutical Co. LTD., holds a position in the pharmaceutical market with its key composition patent expiring in 2028. The drug's primary strength lies in its established market presence, though specific revenue figures are not provided. The primary risk is the potential for increased competition post-patent expiry in 2028.

At a glance

Generic nameTiropramide HCl 100mg
SponsorDaewoong Pharmaceutical Co. LTD.
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tiropramide HCl 100mg

What is Tiropramide HCl 100mg?

Tiropramide HCl 100mg is a Small molecule drug developed by Daewoong Pharmaceutical Co. LTD..

Who makes Tiropramide HCl 100mg?

Tiropramide HCl 100mg is developed and marketed by Daewoong Pharmaceutical Co. LTD. (see full Daewoong Pharmaceutical Co. LTD. pipeline at /company/daewoong-pharmaceutical-co-ltd).

What development phase is Tiropramide HCl 100mg in?

Tiropramide HCl 100mg is FDA-approved (marketed).

Related